86,740 Shares in Ion Beam Applications SA $IOBCF Acquired by Connor Clark & Lunn Investment Management Ltd.

Connor Clark & Lunn Investment Management Ltd. bought a new stake in shares of Ion Beam Applications SA (OTCMKTS:IOBCFFree Report) in the second quarter, Holdings Channel.com reports. The fund bought 86,740 shares of the company’s stock, valued at approximately $9,577,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of IOBCF. Deutsche Bank AG bought a new stake in shares of Ion Beam Applications in the 2nd quarter valued at $10,140,000. BlackRock Inc. bought a new position in Ion Beam Applications during the second quarter worth $488,621,000. Ieq Capital LLC acquired a new position in Ion Beam Applications in the second quarter valued at $4,072,000. EP Wealth Advisors LLC acquired a new position in Ion Beam Applications in the second quarter valued at $271,000. Finally, Allworth Financial LP bought a new stake in Ion Beam Applications during the second quarter valued at $190,000. Institutional investors and hedge funds own 14.86% of the company’s stock.

Ion Beam Applications Trading Down 0.4%

Shares of Ion Beam Applications stock opened at $18.51 on Thursday. The business has a 50-day moving average price of $18.82 and a two-hundred day moving average price of $17.86. Ion Beam Applications SA has a 1-year low of $11.45 and a 1-year high of $20.10.

Ion Beam Applications Profile

(Free Report)

Ion Beam Applications (OTCMKTS: IOBCF) is a Belgium-based medical technology company specializing in the development and deployment of particle therapy solutions for cancer treatment. Founded in 1986 and headquartered in Louvain-la-Neuve, the company is best known for its Proteus® line of proton therapy systems, which are designed to deliver precise, high-energy particle beams that target tumors while sparing healthy tissue. IBA oversees the full project lifecycle, from system design and manufacturing to installation, commissioning, and ongoing service support.

In addition to its flagship proton therapy business, IBA operates a diversified portfolio of technologies for medical and industrial applications.

See Also

Want to see what other hedge funds are holding IOBCF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ion Beam Applications SA (OTCMKTS:IOBCFFree Report).

Institutional Ownership by Quarter for Ion Beam Applications (OTCMKTS:IOBCF)

Receive News & Ratings for Ion Beam Applications Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ion Beam Applications and related companies with MarketBeat.com's FREE daily email newsletter.